Forbion
Forbion is a leading venture capital firm dedicated to building life sciences companies that transform people's lives. The firm collaborates closely with scientists, entrepreneurs, and academic institutions to empower groundbreaking ideas and foster healthcare innovation. With a focus on sustainable and responsible development, Forbion aims to positively impact the health and well-being of patients worldwide.
Forbion
Gooimeer 2-35, 1411 DC Naarden, The Netherlands
What We Do
Forbion supports company formation through BioGeneration Ventures (BGV), focusing on Build, Seed, and Series A rounds.
Forbion Ventures enables and builds new companies, concentrating on Series A and B rounds.
Forbion Growth Opportunities Fund focuses on company expansion through Crossovers, VIPE/PIPE, and Series B/C rounds.
The Forbion BioEconomy Fund supports innovative companies in Food, Agriculture, Materials, and Environmental Technologies sectors, focusing on Series A and B stages.
Portfolio
Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach of reprogramming recombinases.
#Gene Editing
Capstan’s mission is to multiply the therapeutic possibilities for patients by developing targeted in vivo RNA-based therapies.
#RNA-based Therapies
Purespring is leading a revolution in the treatment of kidney diseases, addressing a significant global health issue.
#Kidney Diseases
Marea Therapeutics leverages large-scale human genetics to advance a clinical-stage pipeline of first-in-class treatments.
#Cardiometabolic Diseases
Key People
Partner
General Partner IR & Impact
Associate
Senior Associate
General Partner
Managing Partner
Operating Partner
Associate
Head of Impact and ESG
Principal
Business Analyst
Chief Compliance Officer & Legal Affairs
Managing Partner